FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 344:1174 April 12, 2001 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Edited by Lawrence R. Stanberry and David I. Bernstein. 468 pp., illustrated. San Diego, Calif., Academic Press, 2000. $119.95. ISBN 0-12-663330-4.

Because they frequently go undiagnosed or untreated, sexually transmitted infections remain a major public health problem, in spite of the existence of tools to control them. Now, with the increasing resistance to antibiotics of some of the sexually transmitted pathogens, windows of opportunity for the cost-effective control of sexually transmitted diseases are closing. Gonorrhea, for example, which could be treated easily with affordable penicillin and tetracycline during the 1960s, has remained unchecked in many countries, including those of sub-Saharan Africa. Today, with increasing resistance, the failure of treatment for gonorrhea with penicillin and tetracycline is high, the cost of treatment . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.